Vorinostat Terminated Phase 2 Trials for Mantle Cell Lymphoma (MCL) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01578343Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma